Shanghai, China – On May 25, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") received the CE mark approval for its in-house developed ARBORES™ Kyphoplastic Balloon Catheter ("ARBORES™"), marking the official entry of MicroPort®'s first orthopedic balloon catheter into the European market.
ARBORES™ is intended to be used for the reduction of fractures and/or creation of a void in cancellous bone in the spine, including use during balloon kyphoplasty with accessories like balloon pump, puncture needle, expander and etc. ARBORES™ has two balloon shapes which are Peanut-type and Cylinder-type, and the balloon length ranges from 10mm to 20mm. The overall performance of ARBORES™ is comparable with international leading products. With its CE mark approval of ARBORES™, MicroPort® further diversifies its balloon catheter product line. It is expected that he excellent performance of ARBORES™ will help MicroPort® to expand the European market.